BACKGROUND: Growth differentiation factor 15 (GDF15), a stress-responsive cytokine produced in cardiovascular cells under conditions of inflammation and oxidative stress, is emerging as an important prognostic marker in individuals with and without existing cardiovascular disease (CVD). We therefore examined the clinical and genetic correlates of circulating GDF15 concentrations, which have not been investigated collectively. METHODS: Plasma GDF15 concentrations were measured in 2991 participants in the Framingham Offspring Study who were free of clinically overt CVD (mean age, 59 years; 56% women). Clinical correlates of GDF15 were examined in multivariable analyses. We then conducted a genomewide association study of the GDF15 concentration that included participants in the Framingham Offspring Study and participants in the PIVUS (Prospective Investigation of the Vasculature in Uppsala Seniors) study. RESULTS: GDF15 was positively associated with age, smoking, antihypertensive treatment, diabetes, worse kidney function, and use of nonsteroidal antiinflammatory drugs (NSAIDs), but it was negatively associated with total cholesterol and HDL cholesterol. Clinical correlates accounted for 38% of interindividual variation in the circulating GDF15 concentration, whereas genetic factors accounted for up to 38% of the residual variability (h(2) = 0.38; P = 2.5 × 10(-11)). We identified 1 locus of genomewide significance. This locus, which is on chromosome 19p13.11 and includes the GDF15 gene, is associated with GDF15 concentration (smallest P = 2.74 × 10(-32) for rs888663). Conditional analyses revealed 2 independent association signals at this locus (rs888663 and rs1054564), which were associated with altered cis gene expression in blood cell lines. CONCLUSIONS: In ambulatory individuals, both cardiometabolic risk factors and genetic factors play important roles in determining circulating GDF15 concentrations and contribute similarly to the overall variation.
BACKGROUND:Growth differentiation factor 15 (GDF15), a stress-responsive cytokine produced in cardiovascular cells under conditions of inflammation and oxidative stress, is emerging as an important prognostic marker in individuals with and without existing cardiovascular disease (CVD). We therefore examined the clinical and genetic correlates of circulating GDF15 concentrations, which have not been investigated collectively. METHODS: Plasma GDF15 concentrations were measured in 2991 participants in the Framingham Offspring Study who were free of clinically overt CVD (mean age, 59 years; 56% women). Clinical correlates of GDF15 were examined in multivariable analyses. We then conducted a genomewide association study of the GDF15 concentration that included participants in the Framingham Offspring Study and participants in the PIVUS (Prospective Investigation of the Vasculature in Uppsala Seniors) study. RESULTS:GDF15 was positively associated with age, smoking, antihypertensive treatment, diabetes, worse kidney function, and use of nonsteroidal antiinflammatory drugs (NSAIDs), but it was negatively associated with total cholesterol and HDL cholesterol. Clinical correlates accounted for 38% of interindividual variation in the circulating GDF15 concentration, whereas genetic factors accounted for up to 38% of the residual variability (h(2) = 0.38; P = 2.5 × 10(-11)). We identified 1 locus of genomewide significance. This locus, which is on chromosome 19p13.11 and includes the GDF15 gene, is associated with GDF15 concentration (smallest P = 2.74 × 10(-32) for rs888663). Conditional analyses revealed 2 independent association signals at this locus (rs888663 and rs1054564), which were associated with altered cis gene expression in blood cell lines. CONCLUSIONS: In ambulatory individuals, both cardiometabolic risk factors and genetic factors play important roles in determining circulating GDF15 concentrations and contribute similarly to the overall variation.
Authors: Tibor Kempf; Matthias Eden; Jens Strelau; Marian Naguib; Christian Willenbockel; Jörn Tongers; Jörg Heineke; Daniel Kotlarz; Jian Xu; Jeffery D Molkentin; Hans W Niessen; Helmut Drexler; Kai C Wollert Journal: Circ Res Date: 2006-01-05 Impact factor: 17.367
Authors: Jian Xu; Thomas R Kimball; John N Lorenz; David A Brown; Asne R Bauskin; Raisa Klevitsky; Timothy E Hewett; Samuel N Breit; Jeffery D Molkentin Journal: Circ Res Date: 2006-01-05 Impact factor: 17.367
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Circulation Date: 2005-09-12 Impact factor: 29.690
Authors: Thomas J Wang; Philimon Gona; Martin G Larson; Geoffrey H Tofler; Daniel Levy; Christopher Newton-Cheh; Paul F Jacques; Nader Rifai; Jacob Selhub; Sander J Robins; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan Journal: N Engl J Med Date: 2006-12-21 Impact factor: 91.245
Authors: Tibor Kempf; Rüdiger Horn-Wichmann; Georg Brabant; Timo Peter; Tim Allhoff; Gunnar Klein; Helmut Drexler; Nina Johnston; Lars Wallentin; Kai C Wollert Journal: Clin Chem Date: 2006-12-21 Impact factor: 8.327
Authors: Greisa Vila; Michaela Riedl; Christian Anderwald; Michael Resl; Ammon Handisurya; Martin Clodi; Gerhard Prager; Bernhard Ludvik; Michael Krebs; Anton Luger Journal: Clin Chem Date: 2010-12-16 Impact factor: 8.327
Authors: Asne R Bauskin; David A Brown; Tamara Kuffner; Heiko Johnen; X Wei Luo; Mark Hunter; Samuel N Breit Journal: Cancer Res Date: 2006-05-15 Impact factor: 12.701
Authors: Jing Liu; Sanjeev Kumar; Andreas Heinzel; Michael Gao; Jinjin Guo; Gregory F Alvarado; Roman Reindl-Schwaighofer; A Michaela Krautzberger; Pietro E Cippà; Jill McMahon; Rainer Oberbauer; Andrew P McMahon Journal: J Am Soc Nephrol Date: 2020-02-07 Impact factor: 10.121
Authors: Saskia Koene; Paul de Laat; Doorlène H van Tienoven; Gert Weijers; Dennis Vriens; Fred C G J Sweep; Janneke Timmermans; Livia Kapusta; Mirian C H Janssen; Jan A M Smeitink Journal: JIMD Rep Date: 2015-05-13
Authors: Weronica E Ek; Åsa K Hedman; Stefan Enroth; Andrew P Morris; Cecilia M Lindgren; Anubha Mahajan; Stefan Gustafsson; Ulf Gyllensten; Lars Lind; Åsa Johansson Journal: Hum Mol Genet Date: 2015-12-17 Impact factor: 6.150
Authors: Charlotte Andersson; Sarah R Preis; Alexa Beiser; Charles DeCarli; Kai C Wollert; Thomas J Wang; James L Januzzi; Ramachandran S Vasan; Sudha Seshadri Journal: Stroke Date: 2015-07-28 Impact factor: 7.914